Icaritin inhibits PD‐L1 expression by Targeting Protein IκB Kinase α-Reference-Cited by-同舟云学术

Icaritin inhibits PD‐L1 expression by Targeting Protein IκB Kinase α

Published:2021-02-09 Issue:4 Volume:51 Page:978-988
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Mo Dongliang¹^ORCID,Zhu Hai¹,Wang Jun¹,Hao Haibang¹,Guo Yuming¹,Wang Jiaojiao¹,Han Xu¹,Zou Liangfeng¹,Li Zhongwan¹,Yao Hua¹,Zhu Jinsong²,Zhou Junma¹,Peng Yong¹,Li Jian³^ORCID,Meng Kun¹

Affiliation:

1. Beijing Shenogen Pharma Group. Ltd Beijing P. R. China

2. 13110 NE 177th Place #100 Plexera LLC Woodinville WA USA

3. Institute of Immunology PLA Third Military Medical University (Army Medical University) Chongqing P. R. China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202048905

Reference37 articles.

1. Icaritin Causes Sustained ERK1/2 Activation and Induces Apoptosis in Human Endometrial Cancer Cells

2. A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein

3. A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants

4. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice

5. Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Halogenation on 6-β-anhydroicaritin mediated by DBDMH or DCDMH;Tetrahedron;2024-09

2. Centipeda minima and 6-O-angeloylplenolin enhance the efficacy of immune checkpoint inhibitors in non-small cell lung cancer;Phytomedicine;2024-09

3. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

4. Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies;Cancer Letters;2024-07

5. Conversion therapy of a giant hepatocellular carcinoma with portal vein thrombus and inferior vena cava thrombus: A case report and review of literature;World Journal of Clinical Cases;2024-06-06